Guided Therapeutics, Inc. (OTCQB: GTHPD) today announced its operating results for the fourth quarter and year ended December 31, 2015. Revenue for the fourth quarter ended December 31, 2015 was approximately, $250,000, including $9,000 from grants and contracts....
Guided Therapeutics, Inc. (OTCQB:GTHPD), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that the company has received an order for 2 LuViva® Advanced Cervical Scans, bringing to 5 the number of units...
Guided Therapeutics, Inc. (OTCQB: GTHPD), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will report its 2015 fourth quarter financial results following the market close on Monday, March 14,...
Guided Therapeutics, Inc. (OTCQB: GTHPD), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that the company is now shipping a new screening version of its single-use disposable Cervical Guide designed to...
Guided Therapeutics, Inc. (OTCQB: GTHP) today announced a one-for-one hundred (1:100) reverse split of its issued and outstanding common stock. The reverse stock split will be effective when the market opens on Wednesday, February 24, 2016 and Guided’s common stock...
Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that the company continues to expand in international markets with the signing of a distributor for the Dominican...
